Amiodarone induced thyroid dysfunction: A high cumulative incidence in a nationwide cohort study in Iceland  Journal of Internal Medicine. 2025;298(3):228–236
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40637127

Association of Weekend Warrior and Other Physical Activity Patterns With Mortality Among Adults With Diabetes : A Cohort Study  Annals of Internal Medicine. 2025;178(9):1279–1286
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40690774

The Combination of Afternoon and Midnight Salivary Cortisol Improves the Diagnosis of Cushing Syndrome  American Journal of Medicine. 2025;138(9):1296–1303
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40414476

Comparing glycaemic outcomes of digital and paper-based hospitals (GOOD study)  Internal Medicine Journal. 2025;55(9):1508–1515
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40396617

Consumption of Fruit Juice and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Prospective Cohort Studies  American Journal of Medicine. 2025;138(10):1428–1437
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40393612

Development of Graves’ Disease after Resection of an Autonomously Functioning Thyroid Nodule  Internal Medicine. 2025;64(18):2728–2732
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40128986

Diagnosis and Treatment of Type 2 Diabetes in Adults: A Review  JAMA. 2025;334(11):984–1002
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40549398

Evaluating the prevalence and severity of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care  Journal of Internal Medicine. 2025;298(3):173–187
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40518766

Glucagon-Like Peptide-1 Receptor Agonists and Incidence of Dementia Among Older Adults With Type 2 Diabetes : A Target Trial Emulation  Annals of Internal Medicine. 2025;178(9):1258–1267
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40690769

Glucagon-Like Peptide-1 Receptor Agonists and Risk for Gastroesophageal Reflux Disease in Patients With Type 2 Diabetes : A Population-Based Cohort Study  Annals of Internal Medicine. 2025;178(9):1268–1278
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40658955

How should glucocorticoid and mineralocorticoid replacement be optimised in a young patient with classic 21-hydroxylase congenital adrenal hyperplasia?  Internal Medicine Journal. 2025;55(9):1427–1432
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40728381

Minimum effective low dose of antithymocyte globulin in people aged 5-25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial  Lancet. 2025;406(10510):1375–1388
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40976248

Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity - A Phase 2 Trial  New England Journal of Medicine. 2025;393(9):843–857
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40549887

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes  New England Journal of Medicine. 2025;393(11):1065–1076
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40544435

Scoping Review of the Health Benefits of Stretching Exercises in Patients with Type 2 Diabetes Mellitus  Internal Medicine. 2025;64(18):2681–2691
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40159156

Significance of an Early Diagnosis of Autoimmune Gastritis in Nonelderly Patients with Type 1 Diabetes Mellitus and Autoimmune Thyroid Disease  Internal Medicine. 2025;64(17):2587–2591
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39971298

Socioeconomic Deprivation, Unhealthy Lifestyle, and Premature Mortality in Patients With Type 2 Diabetes: A Population-Based Longitudinal Study  American Journal of Medicine. 2025;138(9):1248–1256.e7
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40334765

Soluble urokinase plasminogen activator receptor and interleukin-6 improves prediction of all-cause mortality and major adverse cardiovascular events in Type 1 diabetes  Journal of Internal Medicine. 2025;298(3):188–199
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40619914

Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes  New England Journal of Medicine. 2025;393(9):858–868
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40544428

Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression  New England Journal of Medicine. 2025;393(9):887–894
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40757665

TAFRO Syndrome with Massive Bilateral Adrenal Hemorrhage  Internal Medicine. 2025;64(17):2604–2609
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40058867

Time restricted eating and exercise training before and during pregnancy for people with increased risk of gestational diabetes: single centre randomised controlled trial (BEFORE THE BEGINNING)  BMJ. 2025;390:e083398
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40925657

Treatment With Canagliflozin Versus Placebo in Children and Adolescents With Type 2 Diabetes : A Randomized Clinical Trial Annals of Internal Medicine. 2025;178(9):1217–1226
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40759025

Type 2 Diabetes Health Care Outcomes for Patients with Alcohol Use Disorder Starting Addiction Treatment  Journal of General Internal Medicine. 2025;40(12):2934–2943
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39627543

Use of dipeptidyl peptidase-4 inhibitors is associated with lower risk of severe renal outcomes in pre-dialysis patients with Type 2 diabetes  Journal of Internal Medicine. 2025;298(3):214–227
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40611400